Non alcoholic hepatitis b and c negative causes of cld

Reading File
Finding Sources
Finding Sources
Searching PubMed

"chronic liver disease" AND etiology AND "non-alcoholic" AND "hepatitis B negative"

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive information from multiple authoritative textbooks. Here is a thorough answer:

Non-Alcoholic, Hepatitis B & C Negative Causes of Chronic Liver Disease (CLD)

Excluding alcohol, hepatitis B, and hepatitis C - the three most common causes worldwide - the following categories account for CLD/cirrhosis:

1. Metabolic/Steatotic Liver Disease

  • NAFLD/NASH (Non-alcoholic fatty liver disease / Non-alcoholic steatohepatitis) - now the most common cause of CLD globally, strongly linked to obesity, type 2 diabetes, dyslipidemia, and metabolic syndrome. Approximately 1 in 10 NASH patients progress to cirrhosis. Many cases of previously labeled "cryptogenic cirrhosis" are now recognised as undetected NASH.

2. Genetic/Inherited Metabolic Disorders

ConditionMechanism
Hereditary HemochromatosisIron overload (HFE gene mutations - C282Y, H63D; also HJV, HAMP, TFR2, ferroportin)
Wilson's DiseaseCopper overload (ATP7B gene mutation)
Alpha-1 Antitrypsin DeficiencyMisfolded protein accumulates in hepatocytes
Glycogen Storage DiseaseTypes IA, III, and IV
TyrosinemiaToxic metabolite accumulation
GalactosemiaGalactose-1-phosphate uridyltransferase deficiency

3. Autoimmune Liver Diseases

  • Autoimmune Hepatitis (AIH) - Immune-mediated destruction of hepatocytes; often responds to immunosuppression
  • Primary Biliary Cholangitis (PBC) - Autoimmune destruction of small intrahepatic bile ducts; presents with malaise, pruritus, and cholestasis; mainly affects middle-aged women
  • Primary Sclerosing Cholangitis (PSC) - Progressive inflammation and fibrosis of intra- and extra-hepatic biliary tree; strongly associated with ulcerative colitis; mainly affects young men; high risk of cholangiocarcinoma

4. Vascular/Outflow Disorders

  • Budd-Chiari Syndrome - Hepatic vein thrombosis causing outflow obstruction; presents with ascites, hepatomegaly, and pain
  • Cardiac cirrhosis / Chronic congestive heart failure - Right-sided heart failure causing chronic hepatic venous congestion
  • Sinusoidal obstruction syndrome (veno-occlusive disease)

5. Drug-Induced Liver Injury (DILI) / Toxins

  • Methotrexate (long-term use)
  • Amiodarone
  • Isoniazid, rifampicin
  • Herbal supplements and traditional medicines
  • Carbon tetrachloride and industrial solvents

6. Parasitic/Infectious (Non-viral)

  • Schistosomiasis - Causes periportal (pipestem) fibrosis; major cause in endemic regions (Africa, South America, South/East Asia)

7. Biliary Causes

  • Biliary atresia (neonatal/pediatric)
  • Caroli's disease - Congenital cystic dilation of intrahepatic bile ducts
  • Chronic biliary obstruction (stones, strictures)

8. Inflammatory / Granulomatous

  • Sarcoidosis - Hepatic granulomata leading to fibrosis

9. Miscellaneous / Rare

  • Neonatal/congenital alloimmune hepatitis
  • Aceruloplasminemia
  • Congenital atransferrinemia
  • Reye's syndrome (children - following viral illness + aspirin)
  • Acute/chronic fatty liver of pregnancy (rare)

10. Cryptogenic CLD

  • No identifiable cause despite full work-up. The proportion has declined significantly as NASH is increasingly recognised as the underlying etiology in many of these patients.

Key point: NASH/NAFLD is now the leading non-alcoholic, non-viral cause of CLD worldwide and is projected to overtake all other etiologies for liver transplantation indications in the near future.
Sources: Schwartz's Principles of Surgery 11e, p.1390-91 | Yamada's Textbook of Gastroenterology 7e, p.2084-85 | Sleisenger & Fordtran's GI and Liver Disease | Bailey & Love's Surgery 28e

Create a diagnostic flowchart or decision tree for CLD workup

Asking for Preferences
Generating Image
CLD Diagnostic Flowchart
Here is the CLD diagnostic decision tree. The flowchart follows a systematic stepwise approach:
  1. Initial assessment - history, exam, basic labs, and abdominal ultrasound
  2. Common causes first - alcohol, then hepatitis B, then hepatitis C (screen-and-exclude approach)
  3. Metabolic workup - NAFLD/NASH if metabolic risk factors present
  4. Autoimmune panel - AMA, ANA, ASMA, IgG/IgM to differentiate PBC, AIH, and PSC
  5. Genetic/metabolic screen - ferritin/transferrin saturation (hemochromatosis), ceruloplasmin/urine copper (Wilson's), alpha-1 antitrypsin level
  6. Vascular causes - Doppler USS / CT venography for Budd-Chiari and cardiac cirrhosis
  7. Drug/toxin review - DILI
  8. Liver biopsy for unresolved cases - cryptogenic cirrhosis
  9. Final common pathway - all confirmed diagnoses feed into Child-Pugh/MELD scoring, complication management, and transplant evaluation
The color coding uses blue for decisions, orange for investigation steps, green for diagnoses, and red for end-stage management. Let me know if you'd like any section expanded or the layout adjusted.
This is a shared conversation. Sign in to Orris to start your own chat.